Results 121 to 130 of about 1,561,114 (282)
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Neurochemical levels measured by brain MR spectroscopy (MRS) have been proposed as endpoints for clinical trials in early‐stage spinocerebellar ataxia (SCA) trials. We tested their trial‐readiness by quantifying neurochemicals in three affected brain regions in early‐stage cohorts of SCA2 and SCA3, examining their reproducibility in ...
James M. Joers +19 more
wiley +1 more source
Foreword: Strategic Partnerships to Advance Health Equity. [PDF]
Ethn Dis, 2019 Mensah GA.
europepmc +1 more source
Advancing Stroke Clinical Trials Using Community Engagement and Implementation Science Approaches
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Stroke clinical trials are essential for advancing stroke care but can face challenges with recruitment, retention, clinical relevance, and translation into real‐world practice. We propose that integrating community engagement and implementation science approaches into stroke trials can help address these needs.
Lesli E. Skolarus +2 more
wiley +1 more source
The Transformative Potential of Strategic Partnerships to Form a Health Equity Network of the Americas. [PDF]
Ethn Dis, 2019 Rodríguez MA +11 more
europepmc +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Building on our prior Behavioral Risk Factor Surveillance System analysis identifying adults aged 18–39 as the primary driver of the national increase in self‐reported cognitive disability, we examined factors associated with this rise using 2013–2024 U.S. BRFSS data. Methods We analyzed U.S.
Adam de Havenon +9 more
wiley +1 more source
Preventing childhood obesity in Latin America: an agenda for regional research and strategic partnerships. [PDF]
Obes Rev, 2017 Caballero B +3 more
europepmc +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Gliomas have undergone a profound redefinition over the past decade, transitioning from morphology‐based entities to biologically coherent diseases defined by molecular alterations. The 2021 WHO Classification of Tumors of the Central Nervous System and its 2022 update formalize this shift, establishing integrated diagnosis as the global ...
Maria Guarnaccia, Sebastiano Cavallaro
wiley +1 more source
Strategic Public Private Partnerships : Innovation and Development
, 2013 This timely book addresses contemporary and future dynamics of collaboration, combining public, private, and nongovernmental resources at a time when global concerns - ranging from economic insecurity to environmental threats to chronic diseases - cannot
Maurrasse, David J.
core
Safety and Efficacy of GLP‐1 Receptor Agonists in Adults With Epilepsy, Obesity, and Type 2 Diabetes
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Managing obesity in patients with epilepsy is complicated by the weight‐gaining properties of essential antiseizure medications (ASMs) such as valproate and pregabalin. We evaluated the safety and efficacy of initiating glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) in this population.
Hyoshin Son +3 more
wiley +1 more source
Media Release - Generate Design - Creative Partnerships Australia.pdf
, 2015 Media release from Creative Partnerships Australia announcing the federally funded program Generate Design, a business strategy and mentoring program with a $100,00 investment in the growth and development of the Australian graphic design industry.
Creative Partnerships Australia, Creative Industries Innovation Centre
core